A rapid laboratory test for pregnant women to detect Group B strep has been developed and is highly valid, identifying GBS colonization in six and a half hours. This new test could help reduce the overuse of resources and minimize bacterial resistance by targeting patients with threatened preterm labor.
A University of Granada researcher proposes that antibiotic abuse forces bacteria to take up DNA from resistant strains, leading to increased resistance. This stress-induced uptake can also make non-resistant bacteria more virulent, exacerbating the problem.
A study published in Neurosurgery found that patients undergoing cerebral angiography and neurointerventional procedures are at a very low risk of infection, even without preventive antibiotics. The authors suggest that the minimally invasive nature and short duration of these procedures may contribute to this low risk.
New research reveals that antibiotic-resistant Staph bacteria exhibit a seasonal pattern, with community-associated strains more likely to infect children during the summer months. In contrast, healthcare-associated strains are more prevalent among seniors during the winter months.
Research found that stressed bacteria can spontaneously develop resistance to rifampicin, a commonly used antibiotic. This discovery has significant implications for the evolution of antibiotic resistance and may impact treatment options for serious bacterial infections such as tuberculosis and leprosy.
Global antibiotic misuse threatens human health more than the war on illegal drugs. Dr Jonny Anomaly advocates for redirecting funds to curb excessive prescribing and promoting collective action.
A new antibiotic, tedizolid phosphate, has been shown to be effective in treating skin infections with a shorter course than traditional treatments. The study found that the new antibiotic was noninferior to linezolid in both early and sustained clinical responses.
A study found 149 unique antibiotic-resistant genes on Chinese commercial pig farms, with levels 192-28,000 times higher than controls. Daily exposure to antibiotics allows microbes carrying these genes to thrive, posing a potential global risk to human health.
A new investigational antibiotic cream has demonstrated a high cure rate of 81% for cutaneous leishmaniasis, with only minor reactions reported. The treatment offers a safe and effective option for patients, potentially replacing toxic and painful treatments.
Researchers at Harvard's Wyss Institute used sophisticated computer modeling and biotechnology to target ROS production in E. coli, rendering the bacteria more susceptible to existing antibiotics. The study provides a promising approach to boost the global antibiotic arsenal against deadly superbugs like tuberculosis.
Researchers developed an automated device called morbidostat to track the evolution of antibiotic resistance at the genetic level. The team identified key genes involved in creating drug-resistant states and documented real-time changes in genes that gave bacteria an advantage in evolving to outwit antibiotics.
Researchers found a 44% drop in mortality with cefdinir and a 36% drop with amoxicillin when antibiotics were added to therapeutic food treatment. This study has changed how children are treated worldwide, providing a lifesaving impact on hundreds of thousands of children annually.
Researchers discovered that blue light can selectively eradicate Pseudomonas aeruginosa infections of the skin and soft tissues, while preserving the outermost layer. This breakthrough could provide a potential non-toxic approach to treating resistant bacterial infections.
A synthetic corkscrew peptide has been shown to kill antibiotic-resistant Gram-negative bacteria by dissolving their double-layered membranes. The peptide, KLAKLAKKLAKLAK, was effective against a variety of strains of E. coli, A. baumanii, and P. aeruginosa, including multi-drug resistant strains.
Infectious disease experts call for novel approaches to end the growing scourge of 'superbugs,' citing 2 million annual infections and 100,000 deaths. The authors recommend new strategies to prevent infections, encourage economic investment in anti-infective treatments, and alter host-microbe interactions.
A new study found high levels of antibiotic resistance in ornamental fish, with some species showing up to 77% resistance to certain antibiotics. The risk to humans is generally minor, but transmission from tropical fish has been documented and poses a concern for those with compromised immune systems.
A compound from the South African toothbrush tree has been shown to effectively treat tuberculosis by binding to a novel site on DNA gyrase, an enzyme essential for bacterial growth. This discovery offers hope for developing new antibiotics to combat drug-resistant strains of TB.
The Children's Hospital of Philadelphia has been awarded a $2 million grant from the Patient-Centered Outcomes Research Institute to study the effectiveness of different antibiotic treatment options for children returning home after hospitalization. The research aims to inform healthcare decisions and improve patient outcomes.
Researchers have discovered a method to induce sexual reproduction in Penicillium chrysogenum, leading to the development of new strains with improved industrial characteristics. This breakthrough aims to increase penicillin production, making it cheaper to produce, and potentially applicable to other economically important fungi.
A new study found that unnecessary antibiotics increase the risk of recurrence of deadly Clostridium difficile infections. Researchers reviewed patient cases and found that 77% of patients received at least one dose of unnecessary antibiotic, leading to a substantial increased risk of recurrence.
Researchers developed a mathematical model to predict how specific mutations affect antibiotic resistance. They discovered that small changes can increase resistance by up to 500%, challenging the idea of big effects from big changes.
A study published in JAMA Network reveals a high clinical treatment failure rate of nearly 7% for patients treated with cefixime for gonorrhea infections in Toronto. The researchers found that strains with reduced susceptibilities to cefixime were associated with higher rates of clinical failures.
Researchers at EPFL have developed a new tool using optofluidics to observe individual bacteria, revealing that persistent populations are dynamic and can adapt through mutation. This challenges traditional theories of bacterial resistance, offering new insights into the evolution of antibiotic efficacy.
Researchers discovered that bacteria can survive antibiotic exposure through random pulses of the enzyme KatG, which activates the drug isoniazid. This finding may aid in designing new antibacterial treatments, particularly for drug-resistant tuberculosis.
A large European trial confirms that commonly prescribed antibiotics are ineffective for treating acute uncomplicated respiratory infections. Patients given amoxicillin did not recover much quicker or have significantly fewer symptoms, and the treatment appeared to have a limited effect even in older patients.
A new study published in BMJ Open found that high-dose vitamin D supplementation reduced symptoms of respiratory tract infection by almost a quarter and antibiotic use by nearly half in patients with frequent infections. However, the treatment had no significant impact on otherwise healthy individuals.
Scientists have discovered a wealth of new antibiotic substances in the skin of the Russian Brown frog, expanding on previous findings to identify 76 additional compounds with potential medical activity.
Researchers have discovered a soil bacterium that degrades the common veterinary antibiotic sulfamethazine and uses it for growth. This finding challenges existing theories on antibiotic resistance and suggests that soil bacteria may be capable of breaking down antibiotics more rapidly, potentially reducing their impacts.
A study of over 33,000 outpatient male veterans found that a longer duration of antimicrobial treatment did not reduce the risk of early or late recurrence of urinary tract infections (UTIs). The optimal treatment duration for UTI in men is currently unknown.
Researchers developed a low-cost, high-throughput platform for identifying compounds with novel antibiotic properties using a diagnostic panel of bacterial strains. The new strategy promises to streamline the discovery of new antibiotics from natural sources, providing a solution to the looming antibiotic crisis.
Scientists have engineered Escherichia coli bacteria that can deliberately die to protect their population, promoting the survival of survivors. The altruistic behavior emerges after sufficient time has passed and can be controlled by tuning the extent of programmed cell death.
Researchers found that e-visit patients were more likely to receive antibiotics and less likely to have relevant testing ordered by their physicians before receiving medication. Despite this, the study suggests that e-visits can improve access to care and convenience for patients without compromising quality.
Robert E.W. Hancock, a UBC microbiologist, has received the Prix Galien 2012 Research Award for his groundbreaking research on complex interactions between antibiotics and bacteria. His work focuses on developing new therapeutic approaches to infectious diseases like malaria.
Researchers found that antibiotic-resistant E. coli can survive in soil and recolonize in animal guts through pasture, forage or bedding. They propose potential solutions to limit the spread of resistance by isolating residual antibiotics before they interact with soil bacteria.
Researchers found that antibiotic resistance for urinary tract infections increased by over 30% between 1999 and 2010, making treatment more challenging. The Southeast region had the highest burden of antibiotic resistance, while states in New England and Pacific regions showed lower levels of resistance.
Researchers have discovered how a particular type of carbapenemase enzyme reorients bound antibiotics to destroy their antimicrobial activity. This understanding could lead to the design of new drugs that can resist being broken down by such enzymes, helping combat increasing antibiotic resistance.
Researchers found eight different tetracycline resistance genes among US honeybees, but only two or three in honeybees from countries with banned antibiotic use. This suggests that the use of antibiotics may have weakened honeybee wellbeing and reduced their ability to fight off other diseases.
Researchers discovered that powerful antibiotics can only partly block protein synthesis in bacteria, allowing the cells to continue producing proteins that may ultimately lead to their own demise. This finding has significant implications for antibiotic development and could lead to the creation of more effective treatments.
Researchers at North Carolina State University have developed a compound that can reactivate antibiotics against methicillin-resistant Staphylococcus aureus (MRSA), making it effective again. The new compound works by short-circuiting the bacteria's ability to mount a defense against the antibiotic.
New research suggests antibiotics do not effectively treat coughs caused by the common cold in children. Peripheral antitussives, such as levodropropizine, appear to be more effective in relieving cough symptoms. The American College of Chest Physicians recommends these treatments for certain types of cough.
Researchers at Henry Ford Health found a novel therapy that uses donated human stool to treat C.diff infection safe and highly effective, with 43 of 49 patients recovering swiftly. The treatment involves administering the stool mixture through a nasogastric tube or colonscopy.
Researchers at Simon Fraser University have discovered a Trojan horse-like mechanism that enables antibiotics to deliver directly into a bacterial cell. The method uses pilus filaments to transport antibiotics into bacteria, offering a new approach to treat deadly bacterial infections like cholera and Pseudomonas aeruginosa.
A recent study from Henry Ford Hospital found that effective treatment for MRSA-related pneumonia can be achieved within 8-13 days, significantly reducing antibiotic exposure and side effects. Researchers evaluated 115 patients' medical charts and discovered that this shorter treatment duration resulted in the highest survival rate.
Two new tests, Corba NP test and ESBL NDP test, can rapidly detect resistant bacteria in under 2 hours, revolutionizing antibiotic treatment. These tests have excellent sensitivity and reliability, offering a simple and inexpensive solution to combat antibiotic resistance.
Urinary tract infections are a common cause for antibiotic prescriptions, but overusing powerful quinolone antibiotics can lead to bacterial resistance. Experts recommend using targeted older drugs instead, unless necessary, to conserve the effectiveness of all medications.
Researchers have made progress in tackling C. difficile infections using mouse models and human patients, with potential treatments including an oral medication and genetic mutation detection. The studies found that administering an oral supplement can prevent CDI, while detecting a specific gene mutation may predict recurrent infections.
Scientists at Queen's University Belfast have developed a new technique using a cold plasma jet to kill bacteria in biofilms, making it effective against complex organised communities of bacteria. The approach has the potential to control hospital superbugs, including multidrug-resistant bacteria like MRSA.
Researchers have developed a new class of antibiotics that disarm pathogens instead of killing them, effectively treating antibiotic-resistant infections. By blocking the synthesis of endotoxin, a toxic product shed by bacteria, these antibiotics prevent inflammation and protect against potentially lethal infections.
A study of Medicare data found wide variation in antibiotic prescribing for older adults based on region and season, with the South having the highest use and West the lowest. The study highlights the need for targeted quality improvement initiatives to reduce unnecessary antibiotic use.
A hands-on project for high school students in Portugal increased understanding of bacteria, antibiotics, and the dangers of antibiotic resistance. Students found the experience both enjoyable and useful, highlighting the benefits of incorporating hands-on activities into science education.
New guidelines from Infectious Diseases Society of America recommend penicillin or amoxicillin for confirmed strep throat infections. The guidelines also advise against tonsillectomy for children with recurrent strep throat unless in specific cases.
A multicenter trial found that antibiotic treatment with amoxicillin/clavulanate significantly improved clinical cure rates and prolonged the median time to next exacerbation in patients with mild-to-moderate COPD. Patients with elevated capillary C-reactive protein (CRP) levels were more likely to be cured without antibiotics.
Bacteria exhibit social behaviors similar to plants and animals, including cooperation and competition. The study found that certain individuals produce antibiotics to defend against competitors, while others benefit from association with these producers.
Researchers found that a few marine microbes produce natural antibiotics that protect their populations from competitors and neighboring populations. This cooperative behavior, where some individuals act as protectors of the many, is a surprising example of social organization in microbial populations.
Researchers found that high doses of vitamin D, given with antibiotic treatment, accelerate recovery in TB patients by dampening down the body's inflammatory response. Vitamin D supplementation may also benefit patients recovering from pneumonia.
A statistical review of four studies on Lyme disease retreatment suggests flaws in design, analysis, and interpretation that challenge the evidence against treatment. The review found inconclusive results and potential benefits from antibiotics, leading experts to question the guidelines' recommendation against retreatment.
Researchers found that antibiotic concentrations set by regulators are high enough to slow fermentation, allowing pathogens like Salmonella and E. coli to proliferate. Boosting lactic-acid-producing bacteria survival can help mitigate the issue.
A new study suggests that nicotinamide, a form of vitamin B3, can increase the ability of immune cells to kill staph bacteria by 1,000 times. This could offer a new tool in the fight against 'superbugs' and potentially reduce dependence on antibiotics.
Researchers develop smart catheter that senses infection and releases nitric oxide to stop bacterial growth, reducing healthcare-associated infections. The device has shown promising results in lab experiments, with the ability to extend NO release for up to weeks.
Researchers at Université de Montréal have discovered a novel strategy to combat antibiotic-resistant superbugs by targeting virulence factors. By removing these proteins, the body's immune system can eliminate the bacteria, making them harmless.